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WHAT IS THE PROBLEM?
Musculoskeletal disease is a common con-
dition that affects up to one-quarter of the
population over 65 years in many devel-
oped countries. Over 6 million Australians
(1) and 27 million Americans (2) are
affected by some type of musculoskeletal
disorder of which osteoarthritis (OA) is
the most common. Musculoskeletal disor-
ders account for one-fifth of all consul-
tations with general practitioners (3) in
Australia. The total treatment cost of OA
and other musculoskeletal conditions in
Australia was estimated as $55.1 billion
in 2012, and the burden of disease cost
was estimated to be $34.2 billion, based
on a loss of 182,135 disability adjusted life
years (DALYs) (4). In the United States, the
personal and community cost of muscu-
loskeletal diseases including those through
lost wages now approaches $950 billion
(5). The 2010 Global Burden of Disease
Study demonstrates the worldwide scale of
this problem, identifying musculoskeletal
disorders as the second largest contrib-
utor to life lost through disability after
Cancer (6). OA has the highest trajectory
of increasing prevalence across all mus-
culoskeletal conditions (4) and in Aus-
tralia is forecast to become the leading
cause of disability (7). Total joint replace-
ment (TJR), which is not only effective for
improving the quality of life of people with
end-stage OA (8), is also a cost-effective
solution (9).
WHAT IS THE CHALLENGE?
What is required is a system-wide reform of
the management of end-stage OA begin-
ning with how patients with OA are
assessed for referral to orthopedic sur-
geons for TJR, how the appropriateness for
referral is decided, how patients who are
being considered for TJR are re-evaluated
while co-morbidities are addressed, and
finally how patients who are not suitable
for TJR are identified and referred for alter-
nate care. The central theme that unites
these processes and which is the essence
of this grand challenge is improving out-
comes after TJR by determining Appropri-
ate Patient Selection – the right treatment
for the right patient at the right time.
WHAT ARE THE DILEMMASWHEN
CONSIDERING TJR?
Total joint replacement can be the treat-
ment of choice for OA, but there is little
evidence to guide decision-making about
who is most likely to benefit from TJR,
nor the best timing of when surgery should
be performed (10). There are many factors
complicating the decision-making process.
HIGH VOLUME
Referral guidelines for TJR have been pro-
mulgated by many learned colleges and
consumer advocacy groups (11). However,
referrals for TJR are becoming so pro-
lific that the numbers on surgical waiting
lists may rise to unsustainable levels. For
example, the almost 90,000 hip and knee
TJRs performed in Australia (12) in 2011 is
expected to double by 2020 (13). This mir-
rors international change (14) including
the United States, where rises in hip (140%)
and knee (670%) replacements over the
next two decades will result in 570,000 hip
and 3.5 million knee replacements being
performed annually by 2030. The rate of
increase of the utilization of TJR across all
age groups is likely to exceed government
projections and supply (15).
HIGH COST
While TJR for knee and hip OA is a
cost-effective solution (9), the volume of
procedures leads to a high cost burden
for the public and private health sectors
and is a major part of the health expen-
diture spent on treating OA annually (5,
16). A survey of insurer and out of pocket
costs of OA in the United States found
that these costs were not only substantial
and may be prohibitive for those seek-
ing definitive treatment of OA, but that
the greater prevalence of women with OA
and their more intensive use of health care
accounted for two-thirds of the increase
in health care expenditure resulting from
OA (2).
HIGH RISKS
Although common, TJR is mainly per-
formed on older patients with their atten-
dant medical risks. A substantial rise in
obesity is not only leading to more com-
plicated outcomes of TJR surgery, but the
prevalence is overrepresented (40–60%) in
patients presenting for lower limb arthro-
plasty (17–19) increasing the risk for these
high volume procedures.
HIGH DISSATISFACTION
Although the rate of revision surgery for
failed TJR is only 0.5% per annum (20),
making it to appear a highly successful
procedure, 20–40% of patients remain dis-
satisfied. The main reason for this dissat-
isfaction is ongoing pain despite surgically
satisfactory procedures. The rate of revi-
sion surgery alone may be an underesti-
mate of failure of surgery (21) because dis-
satisfied patients continue to make ongo-
ing demands for care from already over-
burdened healthcare resources despite not
undergoing revision surgery.
HIGH VARIABILITY IN SURGEON PRACTICE
Since the inception of the Swedish TJR
registries for hip and knee OA, other
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registries now confirm the highly vari-
able and at times paradoxical practices
amongst surgeons. For example, the Aus-
tralian Orthopaedic Association National
Joint Replacement Registry has reported
that totally cemented and hybrid total
hip replacements consistently outperform
total cementless replacements (20). Yet, the
practice of implanting cementless pros-
thetic replacements continues to increase
(20) with substantial cost implications
because of the large cost differential
between cemented and cementless pros-
theses. How surgeons use data and why
pieces of evidence lack traction remains
unclear.
IMPORTANT ISSUES IN END-STAGE OA
MANAGEMENT
WHOWILL RESPONDWELL TO/BENEFIT MOST
FROM TJR?
Appropriate patient selection and response
to TJR are intimately linked. Yet very lit-
tle work has been done to clarify what is
meant by appropriate patient selection or
to understand what constitutes response
to TJR. Recognizing who are poor respon-
ders, will allow clinicians to direct them to
alternate non-surgical options for manag-
ing their OA or to undergo strategies to
mitigate their risk profile prior to TJR so as
to improve their response to surgery.
IS THE APPLICATION OF TJR EQUITABLE?
Variations in who receive TJR, and ris-
ing health care costs, have contributed to
the need to ensure that the provision of
TJR remains equitable, efficient, and safe
in an environment of cost containment.
The challenge for addressing the increas-
ing demand for TJR is how to distribute
limited resources, with the aim to preserve
equity as part of the National systems of
health care.
HOW SHOULD TJR SERVICE BE DELIVERED IN
THE FUTURE?
The inequity of insurance status’ and
resources means that in some nations one
sector absorbs the burden of TJR in place
of another. For example, almost two-thirds
of TJR in Australia are undertaken in the
private health sector despite only one-third
of Australians having private health insur-
ance. It is not clear if the factors that
drive good and poor response to TJR are
the same in the public as in the private
health arenas. Understanding the epidemi-
ologic differences between patients from
these two insurance categories will help
future planning of service delivery and bet-
ter inform models of care that are already
in place.
WHAT IS THE IMPACT OF REVISION JOINT
REPLACEMENT?
Although prosthetic survival has improved
significantly over the last two decades, the
effect of rising numbers of primary TJRs
is to increase the pool of patients who
will require revision surgery in the future
(22). The benefits of the current technology
in enhancing fixation were not available
before two decades or more and a surge in
the requirement and expenditure for revi-
sion can be expected from TJR performed
in the short term. It is anticipated that
younger patients will comprise up to 50%
of those requiring revision surgery (23).
WHAT IS REQUIRED?
Improving the paradigm of care for people
with OA is a bold and challenging task.
What is required is to (i) build a world-class
critical mass of expertise and resources
harnessed from the best groups and
institutions in the field, (ii) coordinate
nationwide research to tackle the compo-
nent parts of OA care, (iii) fertilize and
link individual group research through
broader collaboration, (iv) enhance mus-
culoskeletal research through sharing and
developing critical yet sparse skills sets
such as health economics and agent-based
research, (v) promote and facilitate mul-
tidisciplinary research approach through
comprehensive stakeholder engagement,
(vi) build a force of future researchers
that will drive innovation and trans-
lation, (vii) bring together groups and
resources to create opportunities for fund-
able research focused specifically at mus-
culoskeletal health, and (viii) accrue data
through the diligent use of joint replace-
ment registries that will identify patterns
of prosthetic performance that will inform
safe, cost-effective, and sustainable strate-
gies for TJR.
All this will not be possible by sin-
gle institutions and informal collabora-
tions alone. What is required is a con-
certed global effort by national peak
bodies representing not only orthopedic
surgeons but also other stakeholders to
unite with funding and government agen-
cies to develop context-specific strategies
for addressing the demands, minimizing
complications, improving outcomes and
patient satisfaction, reducing costs, and
increasing effectiveness and advantages, of
primary and revision TJR. Creating the evi-
dence to support all this is the grand chal-
lenge.
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